Objectives: This study sought to compare the 2-year outcomes between bioresorbable
vascular scaffold (BVS) and everolimus-eluting metallic drug-eluting stent (EES) …

Introduction: The first-generation bioresorbable scaffolds (BRSs) had a large strut profile to
compensate for the insufficient radial strength of bioresorbable polymer materials, resulting …

Abstract Background Magnesium-based bioresorbable Magmaris stents are rapidly
resorbed. Few randomized studies have evaluated the efficacy of such stents in patients with …

Percutaneous coronary interventions with stent-based restorations of vessel patency have
become the gold standard in the treatment of acute coronary states. Bioresorbable vascular …

Background: The development of bioresorbable vascular scaffolds (BVS) aimed at
improving the long-term safety profile of PCI. However, there is scarce data on the rate of …

Introduction: Ischemic heart disease is the most common cause of mortality worldwide. In ST
elevation myocardial infarction (STEMI) patients, optimization of primary percutaneous …

Background: Percutaneous coronary interventions to implant bioresorbable vascular
scaffolds (BVSs) were designed to reduce the late thrombotic events that occur with metallic …

Abstract Background Bioresorbable scaffold (BRS) Absorb™ clinical use has been stopped
due to higher rate of device thrombosis. Scaffold struts persist longer than 2 years in the …

Bioresorbable vascular scaffolds (BRS) represent the latest innovation in the field of
interventional cardiology. BRS have recently been introduced in routine clinical practice and …

Background The bioresorbable vascular scaffold (BVS) represents a novel technology
designed to overcome the long-term limitations of metallic coronary stent implantation in …